Lipoglycopeptides

active
URL
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.841
Version
20240226
PublisherOptum StewardDate2024-02-26T01:18:44-05:00Purpose

(Clinical Focus: This set of values includes select antibiotics that are Lipoglycopeptides. Including oral and IV formulations.),(Data Element Scope: The intent of this data element is to identify patients who are on Lipoglycopeptides antibiotics),(Inclusion Criteria: Only use codes that represent Lipoglycopeptides antibiotics and any that has the ingredients as Lipoglycopeptides: dalbavancin, oritavancin, telavancin, vancomycin.),(Exclusion Criteria: Otic, Topical and Ophthalmic formulation. Bleomycin is excluded as it is not used as an anti-infective.)

Expansion
<<>>>
CodeDisplaySystem
1806674http://www.nlm.nih.gov/research/umls/rxnorm
2049887http://www.nlm.nih.gov/research/umls/rxnorm
1807513http://www.nlm.nih.gov/research/umls/rxnorm
2532363http://www.nlm.nih.gov/research/umls/rxnorm
864628http://www.nlm.nih.gov/research/umls/rxnorm
2049889http://www.nlm.nih.gov/research/umls/rxnorm
2532365http://www.nlm.nih.gov/research/umls/rxnorm
2000129http://www.nlm.nih.gov/research/umls/rxnorm
374281http://www.nlm.nih.gov/research/umls/rxnorm
2000127http://www.nlm.nih.gov/research/umls/rxnorm
1728080http://www.nlm.nih.gov/research/umls/rxnorm
1539241http://www.nlm.nih.gov/research/umls/rxnorm
202368http://www.nlm.nih.gov/research/umls/rxnorm
1806678http://www.nlm.nih.gov/research/umls/rxnorm
1807507http://www.nlm.nih.gov/research/umls/rxnorm
1547616http://www.nlm.nih.gov/research/umls/rxnorm
375983http://www.nlm.nih.gov/research/umls/rxnorm
1807512http://www.nlm.nih.gov/research/umls/rxnorm
239209http://www.nlm.nih.gov/research/umls/rxnorm
1547611http://www.nlm.nih.gov/research/umls/rxnorm